In 2021,138,825 people died from COPD in the U.S., making it the sixth overall leading cause of death and the fifth ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.
Children who start smoking prior to age 15 have a 27% increased risk of developing chronic obstructive pulmonary disease ( COPD) as adults, compared to those who started smoking later, researchers ...
Childhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...
A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...
Individuals in the lowest quintile of birth weight appear to have an increased risk for subsequent chronic obstructive ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Smoke from wildfires — like the ones in Los Angeles — can have health consequences. Here's what experts expect.
TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).